Company / Revenue per Share
NovoCure Ltd Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$6.04
FY2025
5-year range
$4.85 / $6.04
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#126 of 147
Health Care
What the data says
NovoCure Ltd's revenue per share of $6.04 is lower than 86% of companies in the Health Care sector (FY2025). Improved from $4.85 to $6.04 over the past 2 years.
Based on SEC 10-K filings.
6.04 in FY2025 with a 5-year CAGR of +4.0%.
Improved from $4.85 to $6.04 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 147This company $6.04 Sector average $128.17
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 6.8% year-over-year.
- Ranks #126 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.04 | +6.8% |
| FY2024 | $5.65 | +16.6% |
| FY2023 | $4.85 | -6.3% |
| FY2022 | $5.17 | -1.1% |
| FY2021 | $5.23 | +5.3% |
| FY2020 | $4.97 | +31.8% |
| FY2019 | $3.77 | +35.9% |
| FY2018 | $2.77 | +36.4% |
| FY2017 | $2.03 | +105.5% |
| FY2016 | $0.99 | -59.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026